References
- Baig AM , KhaleeqA , AliU , SyedaH. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci.11(7), 995–998 (2020).
- Lamprinou M , SachinidisA , StamoulaE , VavilisT , PapazisisG. COVID-19 vaccines adverse events: potential molecular mechanisms. Immunol. Res.6, 1–17 (2023).
- Lu L , XiongW , MuJet al. The potential neurological effect of the COVID-19 vaccines: a review. Acta Neurol. Scand.144(1), 3–12 (2021).
- Mastropaolo M , HasbaniMJ. Small fiber neuropathy triggered by COVID-19 vaccination: association with FGFR3 autoantibodies and improvement during intravenous immunoglobulin treatment. Case Rep. Neurol.15(1), 6–10 (2023).
- Hosseini R , AskariN. A review of neurological side effects of COVID-19 vaccination. Eur. J. Med. Res.28(1), 102 (2023).
- Nabizadeh F , NooriM , RahmaniS , HosseiniH. Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: a systematic review. J. Clin. Neurosci.111, 57–70 (2023).
- Alqatari S , IsmailM , HasanMet al. Emergence of post COVID-19 vaccine autoimmune diseases: a single center study. Infect. Drug Resist.16, 1263–1278 (2023).
- Frontera JA , TamborskaAA , DoheimMFet al. Neurological events reported after COVID-19 vaccines: an analysis of VAERS. Ann. Neurol.91(6), 756–719 (2022).
- Rastogi A , BingelieneA , StrafellaAP , Tang-WaiDF , WuPE , MandellDM. Reversible neurological and brain MRI changes following COVID-19 vaccination: a case report. J. Neuroradiol.49(6), 428–430 (2022).
- Oh J , ChoWH , BarcelonE , KimKH , HongJ , LeeSJ. SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal death. Sci. Rep.12(1), 5496 (2022).
- Baig AM , GreigNH , GerlachJet al. Underlying causes and treatment modalities for neurological deficits in COVID-19 and long-COVID. ACS Chem. Neurosci.13(20), 2934–2938 (2022).
- Hammarström P , NyströmS. Viruses and amyloids – a vicious liaison. Prion17(1), 82–104 (2023).
- Hsueh SC , ScerbaMT , TweedieDet al. Activity of a novel anti-inflammatory agent F-3,6'-dithiopomalidomide as a treatment for traumatic brain injury. Biomedicines10(10), 2449 (2022).
- Lecca D , HsuehSC , LuoWet al. Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury. J. Biomed. Sci.30(1), 16 (2023).
- Yonker LM , SwankZ , BartschYCet al. Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis. Circulation147(11), 867–876 (2023).
- Altman NL , BerningAA , MannSCet al. Vaccination-associated myocarditis and myocardial injury. Circ. Res.132(10), 1338–1357 (2023).
- García-Grimshaw M , Ceballos-LiceagaSE , Hernández-VanegasLEet al. Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study. Clin. Immunol.229, 108786 (2021).
- Bonzano L , DjuricO , MancusoPet al. Incidence and characteristics of adverse events after COVID-19 vaccination in a population-based programme. Vaccines (Basel)10(7), 1111 (2022).